• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自发性细菌性腹膜炎的一级和二级预防:最新进展。

Primary and secondary prophylaxis of spontaneous bacterial peritonitis: current state of the art.

机构信息

a Department of Medical Sciences, Ospedali Riuniti di Foggia , Foggia , Italy.

b Department of Radiology, Azienda Ospedaliero-Universitaria Pisana , Pisa , Italy.

出版信息

Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):751-759. doi: 10.1080/17474124.2019.1644167. Epub 2019 Jul 18.

DOI:10.1080/17474124.2019.1644167
PMID:31304804
Abstract

: Spontaneous bacterial peritonitis represents a frequent and severe complication in cirrhotic patients with ascites. In daily practice, the diagnosis of spontaneous bacterial peritonitis might be challenging in the absence of the typical signs and symptoms of infection such as fever or leukocytosis. : Aim of this review is to revise the current state of the art on primary and secondary spontaneous bacterial peritonitis. Literature search in Medline/Pubmed was performed. : Historically, gram-negative bacteria were the most frequent etiologic agents of spontaneous bacterial peritonitis, with and spp. being the most frequently isolated bacteria. However, major changes in this regard occurred over the last few decades with an increasing prevalence of gram-positive, quinolone-resistant, and multidrug-resistant bacteria. In particular, the increasing prevalence of quinolone-resistant bacteria challenged the prominent role of norfloxacin in spontaneous bacterial peritonitis prevention. Given the high mortality rate and the risk of developing the hepatorenal syndrome, prophylaxis of spontaneous bacterial peritonitis is indicated in three high-risk populations: patients with acute gastrointestinal hemorrhage, patients with low total protein content in ascitic fluid and advanced cirrhosis, and patients with a previous history of spontaneous bacterial peritonitis (secondary prophylaxis).

摘要

自发性细菌性腹膜炎是肝硬化腹水患者的一种常见且严重的并发症。在日常实践中,如果没有感染的典型症状和体征,如发热或白细胞增多,自发性细菌性腹膜炎的诊断可能具有挑战性。本文旨在综述原发性和复发性自发性细菌性腹膜炎的最新研究进展。在 Medline/Pubmed 上进行了文献检索。

在历史上,革兰氏阴性菌是自发性细菌性腹膜炎最常见的病原体, 和 是最常分离到的细菌。然而,在过去几十年中,这方面发生了重大变化,革兰氏阳性、喹诺酮类耐药和多药耐药菌的流行率不断上升。特别是,喹诺酮类耐药菌的流行挑战了诺氟沙星在自发性细菌性腹膜炎预防中的突出地位。鉴于高死亡率和肝肾功能衰竭综合征的风险,自发性细菌性腹膜炎的预防适用于三个高危人群:急性胃肠道出血患者、腹水总蛋白含量低和肝硬化晚期患者以及有自发性细菌性腹膜炎病史的患者(二级预防)。

相似文献

1
Primary and secondary prophylaxis of spontaneous bacterial peritonitis: current state of the art.自发性细菌性腹膜炎的一级和二级预防:最新进展。
Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):751-759. doi: 10.1080/17474124.2019.1644167. Epub 2019 Jul 18.
2
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.自发性细菌性腹膜炎的一级预防可延缓肝肾综合征并提高肝硬化患者的生存率。
Gastroenterology. 2007 Sep;133(3):818-24. doi: 10.1053/j.gastro.2007.06.065. Epub 2007 Jul 3.
3
Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.利福昔明与诺氟沙星用于自发性细菌性腹膜炎二级预防的随机对照试验。
Eur J Gastroenterol Hepatol. 2016 Dec;28(12):1450-1454. doi: 10.1097/MEG.0000000000000724.
4
Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.诺氟沙星连续预防与住院预防自发性细菌性腹膜炎首发发作的比较
Hepatology. 1997 Mar;25(3):532-6. doi: 10.1002/hep.510250306.
5
Treatment of Spontaneous Bacterial Peritonitis.自发性细菌性腹膜炎的治疗
Dig Dis. 2015;33(4):582-5. doi: 10.1159/000375358. Epub 2015 Jul 6.
6
[Bacterial infections in liver cirrhosis].[肝硬化中的细菌感染]
Orv Hetil. 2007 Mar 4;148(9):387-95. doi: 10.1556/OH.2007.27882.
7
[Spontaneous bacterial peritonitis, a severe complication in patients with liver cirrhosis].[自发性细菌性腹膜炎,肝硬化患者的一种严重并发症]
Ned Tijdschr Geneeskd. 2007 Mar 3;151(9):509-13.
8
Current Management of the Complications of Cirrhosis and Portal Hypertension: Variceal Hemorrhage, Ascites, and Spontaneous Bacterial Peritonitis.肝硬化和门静脉高压并发症的当前管理:静脉曲张出血、腹水和自发性细菌性腹膜炎
Dig Dis. 2016;34(4):382-6. doi: 10.1159/000444551. Epub 2016 May 11.
9
[Spontaneous and secondary bacterial peritonitis in cirrhotic patients with ascites].肝硬化腹水患者的自发性和继发性细菌性腹膜炎
Zentralbl Chir. 2014 Apr;139(2):160-7. doi: 10.1055/s-0031-1283815. Epub 2011 Dec 5.
10
Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin.接受诺氟沙星二级预防的肝硬化患者自发性细菌性腹膜炎复发情况。
Eur J Gastroenterol Hepatol. 2019 Apr;31(4):540-546. doi: 10.1097/MEG.0000000000001331.

引用本文的文献

1
Bacterial Infections in Acute-on-chronic Liver Failure: Epidemiology, Diagnosis, Pathogenesis, and Management.慢性肝衰竭急性发作时的细菌感染:流行病学、诊断、发病机制及管理
J Clin Transl Hepatol. 2024 Jul 28;12(7):667-676. doi: 10.14218/JCTH.2024.00137. Epub 2024 Jun 20.
2
Use of Bacterial DNA Concentration in Ascites as a Marker for Spontaneous Bacterial Peritonitis.腹水细菌DNA浓度作为自发性细菌性腹膜炎标志物的应用
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101434. doi: 10.1016/j.jceh.2024.101434. Epub 2024 May 1.
3
Comparative study of virulence potential, phylogenetic origin, CRISPR- regions and drug resistance of isolates from urine and other clinical materials.
尿液及其他临床样本分离株的毒力潜能、系统发育起源、CRISPR区域及耐药性的比较研究
Front Microbiol. 2023 Nov 29;14:1289683. doi: 10.3389/fmicb.2023.1289683. eCollection 2023.
4
Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis.诺氟沙星与其他抗生素预防肝硬化自发性细菌性腹膜炎的比较:系统评价和荟萃分析。
BMC Infect Dis. 2023 Aug 28;23(1):557. doi: 10.1186/s12879-023-08557-6.
5
Procalcitonin and C-reactive protein in the diagnosis of spontaneous bacterial peritonitis.降钙素原和C反应蛋白在自发性细菌性腹膜炎诊断中的应用
Transl Gastroenterol Hepatol. 2022 Oct 25;7:36. doi: 10.21037/tgh-19-297. eCollection 2022.
6
Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative Review.肝硬化患者多重耐药菌感染的患病率及治疗管理:一项叙述性综述
Antibiotics (Basel). 2022 Feb 11;11(2):232. doi: 10.3390/antibiotics11020232.
7
GPR35 promotes neutrophil recruitment in response to serotonin metabolite 5-HIAA.GPR35 促进中性粒细胞对血清素代谢产物 5-HIAA 的募集。
Cell. 2022 Mar 3;185(5):815-830.e19. doi: 10.1016/j.cell.2022.01.010. Epub 2022 Feb 10.
8
A Rare Case of Recurrent Generalized Peritonitis Caused by Spontaneous Urinary Bladder Rupture after Radiotherapy: A Case Report and Literature Review.放疗后自发性膀胱破裂导致复发性弥漫性腹膜炎1例罕见病例:病例报告及文献复习
Medicines (Basel). 2021 Nov 5;8(11):67. doi: 10.3390/medicines8110067.
9
Recent advances in the understanding and management of hepatorenal syndrome.肝肾综合征理解与管理的最新进展
Fac Rev. 2021 May 21;10:48. doi: 10.12703/r/10-48. eCollection 2021.
10
Hepatorenal Syndrome Type 1: Current Challenges And Future Prospects.1型肝肾综合征:当前挑战与未来前景
Ther Clin Risk Manag. 2019 Nov 27;15:1383-1391. doi: 10.2147/TCRM.S205328. eCollection 2019.